Please Note: 

• All session times for the Cancer Discovery 10th Anniversary Symposium: The Next Decade of Discoveries are U.S. Eastern Daylight Time (EDT).
• Recorded presentations available now to all registrants.

*Talk times are approximate

Day 1: JUNE 21, 12-5 P.M. EDT

Welcome and Introductory Remarks
Margaret Foti, American Association for Cancer Research Philadelphia, Pennsylvania, and Lewis Cantley, Weill Cornell Medicine, New York, New York
12-12:15 P.M.

What is the future of dietary intervention for the treatment and prevention of Cancers?
Lewis Cantley
12:15-12:50 P.M.

Discussion
12:50- 1 P.M.

The mechanistic basis of cancer immunotherapy: Checkpoints in combination
Ira Mellman, Genentech, Inc., San Francisco, California
1-1:30 P.M.

Discussion
1:30-1:50 P.M.

Aging and cancer: The ravages of TIME
Ashani T. Weeraratna, Johns Hopkins University, Baltimore, Maryland
1:50-2:15 P.M.

Discussion
2:15-2:40 P.M.

Microbiota-centered interventions for immune-oncology 2.0
Laurence Zitvogel, Gustave Roussy, Villejuif, France
2:40-3:15 P.M.

Discussion
3:15-3:30 P.M.

Deciphering and targeting clonal hematopoiesis
Ross Levine, Memorial Sloan Kettering Cancer Center, New York, New York
3:30-4:15 P.M.

Discussion
4:15-4:20 P.M.

Panel Discussion (All Speakers)
4:20-5 P.M.

Day 2, June 22, 12-5 P.M. EDT

Introductory Remarks
Luis A. Diaz Jr., Memorial Sloan Kettering Cancer Center, New York, New York
12-12:10 P.M.

The next phase of oncology drug development
Luis A. Diaz Jr.
12:10-12:45 P.M.

Discussion
12:45-1 P.M.

Seeing the future: AI-based risk assessment models
Regina Barzilay, Massachusetts Institute of Technology, Cambridge, Massachusetts
1-1:30 P.M.

Discussion
1:30-1:50 P.M.

Driving transformative change of cancer care with precision medicine
Tony S.K. Mok, Chinese University of Hong Kong, Shatin, Hong Kong
1:50-2:15 P.M.

Discussion
2:15-2:40 P.M.

Learning from children: Designing better clinical trials with their data
Katherine Janeway, Dana–Farber Cancer Institute, Boston, Massachusetts
2:40-3:15 P.M.

Discussion
3:15-3:30 P.M.

Resistance to targeted therapy
Alice T. Shaw, Novartis, Boston, Massachusetts
3:30-4:15 P.M.

Discussion
4:15-4:20 P.M.

Panel Discussion (All Speakers)
4:20-5 P.M.